Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol versus etomidate dose-comparison induction study in elderly hypertensive surgical patients
ChiCTR2400081795Phase 4Not yet recruiting
- Sponsor
- Nanchong City Central Hospital
- Start
- Mar 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and etomidate in hypertension (HTN) (4 arms), sponsored by Nanchong City Central Hospital. Primary endpoints: Changes of mean arterial pressure, Changes of heart rate and 2 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
ciprofoletomidate
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2400081795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081795.